The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma
1997

Chemotherapy Effects on Energy Metabolism in Lung Cancer

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): AJ Staal-van den Brekel, AMWJ Schols, MA Dentener, GPM ten Velde, WA Buurman, EFM Wouters

Primary Institution: University Hospital, Maastricht, The Netherlands

Hypothesis

The study aims to investigate energy metabolism and systemic levels of inflammatory mediators in small-cell lung carcinoma (SCLC) patients before and after chemotherapy.

Conclusion

Chemotherapeutic treatment reduces the tumor-related metabolic derangements and acute-phase response in SCLC patients.

Supporting Evidence

  • Patients showed a significant reduction in resting energy expenditure after chemotherapy.
  • Acute-phase proteins CRP and LBP decreased significantly after treatment.
  • Body weight and body composition remained stable throughout the study.

Takeaway

This study looked at how chemotherapy affects energy use and inflammation in lung cancer patients. It found that chemotherapy helps reduce some of the problems caused by the cancer.

Methodology

Resting energy expenditure (REE) was measured by indirect calorimetry and body composition was assessed by bioelectrical impedance before and after chemotherapy treatment.

Limitations

The follow-up period may be too short to observe changes in body composition, and the study's small sample size limits generalizability.

Participant Demographics

10 men and 2 women, average age 62 years.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication